<DOC>
	<DOCNO>NCT01837199</DOCNO>
	<brief_summary>Randomized control clinical trial demonstrate use amoxicillin ( AMX ) metronidazole ( MTZ ) adjuncts mechanical therapy improve clinical microbiological outcome scale root planing ( SRP ) non-smokers smoker ChP . However , effect antibiotic protocol directly compare non-smokers smoker . Therefore , aim study compare clinical microbiological effect adjunctive use MTZ+AMX SRP smoker non-smokers subject chronic periodontitis ( ChP ) . It hypothesize non-smokers would benefit good combination therapy smoker .</brief_summary>
	<brief_title>MTZ Plus AMX Treatment Smokers Non-smokers</brief_title>
	<detailed_description>Sample size calculation : This study design compare clinical microbiological effect treatment smoker non-smoker subject SRP+MTZ+AMX . The ideal sample size assure adequate power clinical trial calculate consider difference least 1mm group clinical attachment level ( CAL ) initially deep periodontal site ( PD ≥ 7 mm ) . It also determine standard deviation CAL change deep site would 1.0 mm base early study smoker non-smokers receive SRP combine MTZ+AMX . Based calculation , define 26 subject per group would necessary provide 85 % power α 0.01 . Considering attrition 20 % , establish least 32 subject include treatment group . Experimental design treatment protocol : In cohort clinical trial , subject assign accord smoking status , smoker non-smoker group . All subject receive SRP combine systemic MTZ ( 400 mg ) AMX ( 500 mg ) . Both antibiotic administer T.I.D . 14 day . Before study begin , subject receive full-mouth supragingival scale instruction proper home-care technique . They receive dentifrice use study period ( Colgate Total ) . All subject receive full-mouth SRP perform local anesthesia four six appointment last approximately 1h . Treatment entire oral cavity do 14 day . SRP perform one trained periodontist use manual instrument . The antibiotic therapy start immediately first session mechanical instrumentation . The University Pharmacy prepare antibiotic pill send study coordinator , mark code number subject set two pack give examiner . All subject receive clinical microbiological monitoring baseline 3 , 6 12 month post-therapy . Clinical monitoring : One calibrate examiner perform clinical monitoring treatment carry another clinician . Thus , examiner clinician masked nature treatment group . Visible plaque ( presence absence ) , gingival bleeding ( presence absence ) , bleed probe ( BOP ; presence absence ) , suppuration ( presence absence ) , PD ( mm ) clinical attachment level ( CAL , mm ) measure six site per tooth ( mesiobuccal , buccal , distobuccal , distolingual , lingual mesiolingual ) teeth , exclude third molar . The PD CAL measurement record near millimeter use North Carolina periodontal probe . Microbiological Monitoring : Subgingival plaque sample collect baseline 3 , 6 12 month post-SRP nine non-contiguous interproximal site per subject . The select sit randomize different quadrant subset accord baseline PD , three sample follow category : shallow ( PD &lt; 3 mm ) , intermediate ( PD 4-6 mm ) deep ( PD &gt; 7 mm ) . After clinical parameter record , supragingival plaque remove subgingival sample take individual sterile curette ( Gracey # 11-12 ) immediately place separate Eppendorf tube contain 0.15 ml buffer ( TE ) . One hundred microliters 0.5 M sodium hydroxide ( NaOH ) add tube sample disperse use vortex mixer . The sample analyze Checkerboard DNA-DNA hybridization .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Chronic periodontitis ( AAP 1999 ) ; ≥35 year age ; Presence least 15 teeth ; Minimum 6 teeth least one site PD clinical attachment level ( CAL ) ≥5 mm ; At least 30 % site PD CAL ≥4 mm bleed probe ( BOP ) . Smokers : smoke least 10 cigarette per day minimum 5 year ; Nonsmokers : never smoke . Previous subgingival periodontal therapy ; Pregnancy ; Nursing ; Systemic disease could affect progression periodontal disease ( e.g . diabetes , osteoporosis ) ; Longterm administration anti inflammatory medication ; Need antibiotic premedication routine dental therapy ; Continuous use mouthrinses contain antimicrobial ; Antibiotic therapy previous 6 month Allergy MTZ AMX .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Periodontal disease</keyword>
	<keyword>Scaling root planing</keyword>
	<keyword>Metronidazole</keyword>
	<keyword>Amoxicillin</keyword>
	<keyword>Generalized chronic periodontitis</keyword>
	<keyword>Periodontal treatment</keyword>
</DOC>